State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 335 actively recruiting studies with Michigan sites out of 335 registered in total. The busiest research areas in Michigan are Endometrial Cancer, Advanced Solid Tumors, Heart Failure. Leading sponsors running trials in the state include University of Michigan, AstraZeneca, SWOG Cancer Research Network. By stage, Michigan trials break down as Phase 1 (66), Phase 2 (101), Phase 3 (90), Phase 4 (14).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 335 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 335. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Endometrial Cancer, Advanced Solid Tumors, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT06307795 Phase 1
Recruiting
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metast...
Condition
Locally Advanced or Metastatic Solid Tumors
Enrollment
63 pts
Location
United States, Canada, China
Sponsor
Avistone Biotechnology Co., Lt
NCT06667141 Phase 1
Recruiting
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
Condition
Specific Advanced Solid Tumors
Enrollment
100 pts
Location
United States
Sponsor
Acrivon Therapeutics
NCT06477172 N/A
Recruiting
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
Condition
Post Procedural Erythema
Enrollment
500 pts
Location
United States, Canada
Sponsor
Acorn Biolabs Inc.
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT06673095 N/A
Recruiting
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive C...
Condition
Clinical Stage IA Cutaneous Melanoma AJCC v8
Enrollment
1,000 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT06856057 N/A
Recruiting
Improving Behavioral Health for Caregivers and Children After Pediatric Injury
Condition
Quality of Life
Enrollment
348 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06324357 Phase 1, Phase 2
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in...
Condition
Metastatic Breast Cancer
Enrollment
768 pts
Location
United States, Belgium, China
Sponsor
Boehringer Ingelheim
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT06095128 Phase 4
Recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Condition
Ulcerative Colitis
Enrollment
65 pts
Location
United States, Canada
Sponsor
Takeda
NCT06070428 N/A
Recruiting
Project 4: ACHIEVE PATHFINDER
Condition
Heart Failure
Enrollment
400 pts
Location
United States
Sponsor
Henry Ford Health System
NCT06218875 N/A
Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endopros...
Condition
AAA - Abdominal Aortic Aneurysm
Enrollment
2,000 pts
Location
United States, Australia, Austria
Sponsor
W.L.Gore & Associates
NCT04179981 N/A
Recruiting
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veteran...
Condition
Sleep Apnea Syndrome
Enrollment
668 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06975722 Phase 2
Recruiting
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participant...
Condition
Ulcerative Colitis
Enrollment
99 pts
Location
United States, Australia, China
Sponsor
Sanofi
NCT06561165 N/A
Recruiting
Multifocal HD-tDCS and Motor Function
Condition
Healthy
Enrollment
40 pts
Location
United States
Sponsor
University of Michigan
NCT05630794 Phase 1
Recruiting
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Condition
Colorectal Adenomatous Polyp
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT01904851 N/A
Recruiting
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Condition
Peripheral Arterial Disease
Enrollment
14,000 pts
Location
United States
Sponsor
Baylor Research Institute
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06671002 Phase 4
Recruiting
Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial
Condition
Surgery
Enrollment
900 pts
Location
United States
Sponsor
University of Michigan
NCT05133102 N/A
Recruiting
Longitudinal Oral Microbiome Sampling for BE
Condition
Barrett Esophagus
Enrollment
275 pts
Location
United States
Sponsor
Columbia University
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
1,160 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07141706 Phase 1
Recruiting
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
Condition
Advanced/Metastatic Solid Tumors
Enrollment
253 pts
Location
United States, Australia, China
Sponsor
DualityBio Inc.
NCT07304050 N/A
Recruiting
Predicting ICU Transfers and Other Unforeseen Events (PICTURE)-Pediatric
Condition
Clinical Deterioration
Enrollment
375 pts
Location
United States
Sponsor
University of Michigan
NCT05836090 N/A
Recruiting
Family Spirit Strengths
Condition
Depressive Symptoms
Enrollment
188 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School
NCT07599982 N/A
Recruiting
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabet...
Condition
Type 1 Diabetes (T1D)
Enrollment
102 pts
Location
United States
Sponsor
DreaMed Diabetes
NCT07684235 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
3,200 pts
Location
United States, Australia, Japan
Sponsor
Amgen
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology